Industry
Clinical Data to Aquire Genaissance
In a transaction that will combine the capabilities of a classic diagnostic company with a leader in pharmacogenomics, Clinical Data, Inc., has agreed to acquire Genaissance Pharmaceuticals, Inc., in an all-stock transaction valued at around U.S.$56 million. More...29 Jun 2005
In Other News
Alliance to Aid Diagnosis of Depression
Collaboration on DNA Methylation
Alliance for Cytometric Tissue Analysis
VWR Acquires AGB Scientific
Bio-Rad Proposes to Buy BioSource
New Developments at Olympus Diagnostica
Genome Express in Contract with Food Agency
Upstate Obtains Rights to Leukemia Biomarker
Alliance for Neurodegenerative Diagnostics
Abbott and BioCurex Announce Licensing Deal
Developing QC Products for CF Testing
LabCorp to Acquire Esoterix
Subsidiary Formed to Market H Pylori Test
Partnership to Address Lab Needs
R&D Alliance for Cardiac Markers
Alliance for Papillomavirus Assay
Dade Behring Honored With Award
Partnership for Hematology Instruments
Inverness Medical to Acquire Binax
New Technology Licensed to Beckman Coulter
Corgenix Cancels Genesis Bioventures Merger
New Blood-Testing Methods Licensed to Quest
Alliance for New Automation Technologies
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.







